SCHEMBL23122001

SCHEMBL23122001

O=Cc1ccc(CCc2ccccc2)o1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
TSHR P16473 1/20 0.55
PPARG P37231 1/20 0.44
PTGER3 P43115 1/20 0.43
TP53 P04637 1/20 0.42
MDM2 Q00987 1/20 0.42
FAAH O00519 1/20 0.41
KDM4E B2RXH2 3/20 0.40
POLB P06746 2/20 0.40
LMNA P02545 1/20 0.40
DAO P14920 1/20 0.40
CTSL P07711 1/20 0.40
G6PC1 P35575 2/20 0.40
HTR2B P41595 1/20 0.40
HTR3A P46098 1/20 0.40
FFAR1 O14842 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTT P42858 1/20 0.38
MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1244130 0.86 ALDH1A1 (0.57) ALDH1A1TSHRTP53MDM2KDM4E
SCHEMBL14138559 0.79 TSHR (0.49) ALDH1A1TSHRTP53MDM2KDM4E
SCHEMBL22289462 0.79 TSHR (0.50) ALDH1A1TSHRTP53MDM2KDM4E
Aes-103 SCHEMBL28397815 0.76 ALDH1A1 (0.92) ALDH1A1TSHRTP53KDM4EPOLB
SCHEMBL1680546 0.75 ALDH1A1 (0.49) ALDH1A1TSHRTP53MDM2KDM4E
SCHEMBL8640022 0.74 ALDH1A1 (0.61) ALDH1A1TSHRTP53KDM4EPOLB
SCHEMBL16564245 0.74 ALDH1A1 (0.61) ALDH1A1TSHRTP53MDM2KDM4E
SCHEMBL3440182 0.74 ALDH1A1 (0.73) ALDH1A1TSHRTP53KDM4EPOLB
SCHEMBL24401235 0.73 TDP1 (0.60) ALDH1A1POLBDAOFFAR1L3MBTL1
SCHEMBL19415840 0.73 ALDH1A1 (0.50) ALDH1A1TSHRKDM4EPOLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402873-A1 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES AUTOTAC INC. (KR) 2022-12-22 US disclosed
US-20220402873-A1 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES AUTOTAC INC. (KR) 2022-12-22 US disclosed
WO-2021054804-A1 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES 주식회사 오토텍바이오 2021-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402873-A1 NOVEL P62 LIGAND COMPOUND, AND COMPOSITION CONTAINING SAME FOR PREVENTING, AMELIORATING, OR TREATING PROTEINOPATHIES SQSTM1, ATG7, ATG13 ALDH1A1 4802/4885TSHR 4096/4885PPARG 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.